Document Detail

Antihypertensive effect of formononetin through regulating the expressions of eNOS, 5-HT(2A/1B) receptors and α(1)-adrenoceptors in spontaneously hypertensive rat arteries.
MedLine Citation:
PMID:  23123056     Owner:  NLM     Status:  Publisher    
One of the main pathological changes of hypertension is the dysfunction of blood vessels. We have found in our previous study that formononetin, one kind of phytoestrogens, has an acute antihypertensive effect. Therefore, we hypothesized that formononetin might produce a chronic antihypertensive effect through regulating the expressions of contractile receptors and endothelial nitric oxide synthase (eNOS) in artery. The present study was conducted to verify this effect. Male spontaneously hypertensive rats (SHRs) were divided into two groups, orally administrated formononetin (50mg/kg per day) and Tween 80 vehicle, respectively, for 8 weeks. The blood pressure was measured by tail-cuff method. Isometric tension of arterial rings was recorded by a myograph system. The mRNA and protein expression in arteries was determined with quantitative real-time polymerase chain reaction and immunohistochemistry, respectively. Results showed that the systolic blood pressure of SHRs decreased significantly in formononetin group compared to Tween 80 group. The vasoconstriction induced by phenylephrine or 5-hydroxytryptamine (5-HT) in the mesenteric artery segments in formononetin group was decreased, and the relaxation induced by acetylcholine was increased compared with that in Tween 80 group. In the mesenteric arteries of the formononetin-treated SHRs, the expressions of α(1)-adrenoceptors and 5-HT(2A/1B) receptors at both mRNA and protein levels decreased, while the mRNA and protein expressions of eNOS increased. In conclusion, formononetin has a chronic antihypertensive effect in SHRs. The antihypertensive mechanism may be associated with the down-regulation of α(1)-adrenoceptors and 5-HT(2A/1B) receptors, and the up-regulation of eNOS expression in arteries.
Tao Sun; Jie Wang; Lin-Hong Huang; Yong-Xiao Cao
Related Documents :
19059656 - Surveillance of cardiovascular risk in the normotensive patient with repaired aortic co...
12623956 - Contrasting regression of blood pressure and cardiovascular structure in declipped reno...
10941546 - Immediate and late clinical and angiographic outcomes after gfx coronary stenting: is h...
8989336 - Percutaneous transluminal angioplasty for renovascular hypertension in children: initia...
20822786 - Calculation of the effect of pressurizing gases on the resonant modes of single-crystal...
10215716 - Laryngeal mask airway intracuff pressure estimation by digital palpation of the pilot b...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-30
Journal Detail:
Title:  European journal of pharmacology     Volume:  -     ISSN:  1879-0712     ISO Abbreviation:  Eur. J. Pharmacol.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-11-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1254354     Medline TA:  Eur J Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012. Published by Elsevier B.V.
Department of Pharmacology, Xi'an Jiaotong University College of Medicine, Xi'an, Shaanxi, 710061, P. R. China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Protective effect of 2-hydroxy-4-methoxy benzoic acid on testosterone induced benign prostatic hyper...
Next Document:  Excitotoxicity: Bridge to Various Triggers in Neurodegenerative Disorders.